Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...

Pharma major Alembic Pharmaceuticals on Saturday, November 15, announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Alembic Pharmaceuticals just received USFDA approval for its generic version of Dasatinib, a key drug for treating certain types of blood cancer (CML and ALL) in adults, and CML in children. The USFDA ...

Alembic Pharmaceuticals Limited has announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg.

Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market a generic medication to treat acne vulgaris in the US market. The company has received final ...

The company's current liabilities during FY25 stood at Rs 1 billion as compared to Rs 961 million in FY24, thereby witnessing an increase of 32.8%. Long-term debt stood at Rs 107 million as compared ...

Pivya has been proven safe in three studies. Credit: Summit Art Creations/Shutterstock. Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya ...

Alembic Pharmaceuticals on Thursday said its US arm has acquired Utility Therapeutics Ltd in a $12 million (over Rs 100 crore) deal to strengthen its presence in the American market. The acquisition ...

Alembic Pharmaceuticals share price: Pharmaceuticals company Alembic Pharmaceuticals shares were trading higher on Thursday, July 3, 2025, with the scrip rising up to 2.05 per cent to hit an intraday ...

Alembic Pharmaceuticals Inc., the US subsidiary of Alembic Pharmaceuticals, has acquired Utility Therapeutics Ltd in a $12 million deal to strengthen its presence in the US market. Alembic will begin ...